Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06403436
Title A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors (TT-CSP-001)
Acronym TT-CSP-001
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors TOLREMO therapeutics AG
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP | CHE

Facility Status City State Zip Country Details
NEXT Oncology RECRUITING Barcelona 08023 Spain Details
Hospital Vall d'Hebrón RECRUITING Barcelona 08035 Spain Details
NEXT Madrid RECRUITING Madrid 28223 Spain Details
Ente Ospedaliero Cantonale RECRUITING Bellinzona 6500 Switzerland Details
Centre Hospitalier Universitaire Vaudois RECRUITING Lausanne 1890 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field